Approved
consistent with revisions to the CDC Supporting Statement included
in the public docket under supporting statements. Additionally, CDC
acknowledges the limitations of utilizing Knowledge Networks -
specifically that this methodology will not produce representative
or generalizable results.
Inventory as of this Action
Requested
Previously Approved
08/31/2008
12 Months From Approved
4,385
0
0
1,127
0
0
0
0
0
This project involves the evaluation
of the HIV Testing Social Marketing Campaign (HTSMC), a
CDC-sponsored social marketing campaign aimed at increasing HIV
testing rates among young, single, African American women. The CDC
has designed an efficacy study to evaluate the HTSMC and its
messages under controlled conditions. The study entails selecting a
sample of single African American females, ages 18 to 34, with less
than 4 years of college education and collecting baseline data on
their knowledge, attitudes, beliefs, intentions, and behaviors
related to HIV testing. The study represents an ``efficacy''
methodology in that participants will be divided into treatment and
control conditions. Participants in the treatment condition will be
exposed to campaign materials including radio advertisements, a
billboard, and an informational booklet that will be distributed
over the Internet. Thus the study participants' exposure will occur
under controlled conditions, without the distractions and
variability of potential exposure in the real world. As part of the
advertisement stimuli package, the billboard advertisement will
appear as part of the online log-in for each stimuli session in
order to simulate the appearance of a sign. Therefore, we do not
estimate any additional burden for exposure to the billboard
advertisement. Key outcomes related to the HTSMC will be measured
in two follow-up surveys. The first follow-up survey will occur 2
weeks after the baseline survey. The second follow-up survey will
occur 6 weeks after the baseline survey. Comparisons of changes in
these outcomes would then be made between participants in the
treatment and control conditions. Findings from this study will be
used by CDC and its partners to inform current and future program
activities. We expect a total of 1,630 participants to complete the
baseline survey. The 1,630 participants who complete the baseline
survey will be randomly assigned to the treatment or control
condition. 815 participants (the treatment condition) will be
exposed to the radio ad and booklet. Of the 1,630 participants who
completed the baseline survey, we expect 1,140 to complete the
first follow-up survey. Of the 1,140 who complete the first
follow-up survey, we expect 800 to complete the second follow-up
survey, which will have fewer questions than the first follow-up
survey because it will only pertain to questions about behavior
change and selected behavioral intentions. There are no costs to
the respondents other than their time.
US Code:
42
USC 241 Name of Law: Part A. Research and Investigation
General
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.